Author: healthadmin

For decades, beta blockers have been one of the routine medications taken by many patients after a heart attack. They are widely used in heart disease and have long been considered a standard part of recovery after myocardial infarction. But a major clinical trial in 2025 suggests that many people with good heart function who have uncomplicated heart attacks may not benefit at all from taking these drugs. The findings come from the REBOOT trial, a large international study led by senior investigator Valentin Faster, MD, director of Mount Sinai Faster Heart Hospital and executive director of Spain’s Center for…

background Recently, a research team led by Professor Dahong Zhang and Professor Qi Zhang from the Department of Urology, Institute of Urology, and Translational Medicine Center of Zhejiang Provincial People’s Hospital discovered that polyarginine peptide R11, which targets bladder tumors, can directly bind to actin, destabilize G-actin tetramers, and cause cascade disassembly of G-actin tetramers. actin-plectin-vimentin/ITGβ4 axis (referred to as the “cytoskeletal domino effect”). This significantly impairs the migratory ability of bladder cancer (BCa) cells and persistently suppresses metastasis (Figure 1). This study further revealed that presenting R11 in the form of nanoscale multivalent aggregates amplified its actin-disrupting and anti-metastatic…

EHU research shows that vitamin D supplements can help strengthen your immune system, but they have no effect on improving your athletic performance. Eneko Fernandez studied the effects of taking vitamin D as a supplement in runners and non-runners. The results show that it may benefit the body’s defense mechanisms, but has no direct effect on maximal oxygen consumption, explosive leg strength, or isometric muscle strength. The study also showed that runners who trained outdoors had higher vitamin D levels. Vitamin D is important for the body to function properly. Vitamin D balances the immune system, keeps bones healthy, and…

Explore the challenges clinical researchers face with data overload, gene therapy, precision medicine, and AI integration in 2026 clinical trials.

The sound of crickets chirping. A bright flash of orange and black wings flutter around the flowers. Drunk looping grasshopper flight. The familiar sights and sounds of summer in New Mexico are becoming fewer as insect populations decline due to hotter, drier weather, pesticide use and habitat loss. New Mexico, like many other states, is experiencing what experts describe as an alarming decline in insect populations, changes that pose a serious threat to the ecosystem. Although insects are often seen as pests, entomologists told Source NM that an estimated three-quarters of wild plants depend on insects to help them reproduce.…

Targeting senescent cells with dasatinib quercetin preserves disc architecture and modulates degeneration-related pathways in a mouse model. Disc degeneration is a major cause of chronic back and neck pain, but current treatments primarily focus on relieving symptoms rather than preventing disease progression. There is increasing evidence that cellular senescence, in which cells lose their ability to proliferate and secrete inflammatory factors, plays a central role in accelerating the destruction of intervertebral disc tissue. However, it is still not fully understood how genetic susceptibility influences early onset of disease and whether treatments targeting aging can change this trajectory.To address this challenge,…

Specialty care is growing rapidly. Over the next 10 years, the number of adult outpatient visits is expected to increase by 18%. This is because care continues to move away from inpatient care and an aging population is driving demand for specialist services. The growth in the physician workforce has not kept pace. The Association of American Medical Colleges projects a shortage of up to 86,000 physicians by 2036, with specialty care among the hardest-hit fields.Simply put, healthcare professionals are required to see more patients with fewer resources in a reimbursement environment that is becoming more complex every year.None of…

An analysis of Project TALENT data (1960s) found that general mental ability and conscientiousness were the best predictors of a student’s college grade point average (GPA). Contrary to expectations, mathematical knowledge did not improve predictions beyond these two factors. The paper is intelligence and cognitive ability. General mental abilities are the broad abilities to learn, reason, solve problems, understand complex ideas, and adapt to new situations. This includes abilities such as verbal reasoning, numerical reasoning, memory, abstract thinking, and efficient information processing. It predicts how quickly and effectively people can learn new content, make decisions, and perform complex school and…

Author: Guy Amster, Senior Principal Machine Learning Engineer, Flatiron HealthReal-world evidence (RWE) has long held promise to transform the way we understand cancer, turning the realities of everyday patient care into insights that will inform research, clinical development, regulatory decisions, and treatment strategies. In the age of AI, that promise feels closer than ever. But as someone who has spent seven years building AI systems for oncology data, I have seen the gap between what AI can do and what it actually does widen. In a survey of 90 RWD purchasing decision makers, 89% identified data quality and completeness as…

Sydney’s life sciences sector has reached a major milestone, with Clava Group announcing the first certified partner for ION, a purpose-built commercial life sciences precinct designed to redefine Australia’s innovation infrastructure. Clava Group CEO and co-founder Nick Smith and IWG ANZ SVP and country manager Licia Ross following the signing of the partnership agreement between IWG and ION Waterloo. Image credit: ION Located in Waterloo, ION is designed as a purpose-built ecosystem for life sciences, biotech, medical technology, deep tech and pharmaceutical companies, providing the specialized infrastructure needed to support companies from research and discovery to commercial growth. The announcement…